Osteonecrosis in children with acute lymphoblastic leukemia: A 10-year study from Northern Greece [3]

Pediatric Blood and Cancer

Volumn 49, Issue 5, 2007, Pages 764-

  Tragiannidis, Athanassios ^a,c   Athanassiadou, Fani ^a   Papageorgiou, Theodotis ^a   Petsatodis, Georgios ^a   Sidi, Vassiliki ^b   Koliouskas, Dimitrios ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Aristotle University of Thessaloniki   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; DEXAMETHASONE; PREDNISONE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGE DISTRIBUTION; BONE NECROSIS; CHILD; CLINICAL PROTOCOL; FEMALE; GREECE; HIGH RISK PATIENT; HUMAN; INCIDENCE; LETTER; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX RATIO; ACUTE LYMPHOCYTIC LEUKEMIA; INFANT; NOTE; PRESCHOOL CHILD; RISK ASSESSMENT;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; OSTEONECROSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 35148829888     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21141     Document Type: Letter

References (3)

1. Burger B, Beier R, Zimmermann M, et al. Osteonecrosis: A treatment related toxicity in childhood acute lymphoblastic leukemia (ALL): Experiences from trial ALL-BFM 95. Pediatr Blood Cancer 2005;44:220-225.
2. Arico M, Boccalatte MF, Silvestri D, et al. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 2003;88:747-753.
3. Relling M, Yang W, Das S, et al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol 2004;22:3930-3936.